1 | 11595185 | Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. | Cell | 2001 Oct 5 |
1 |
2 | 11805336 | Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function. | Proc Natl Acad Sci U S A | 2002 Jan 22 |
1 |
3 | 11916981 | Mammalian class E vps proteins recognize ubiquitin and act in the removal of endosomal protein-ubiquitin conjugates. | J Cell Biol | 2002 Apr 1 |
2 |
4 | 12006492 | Structure and functional interactions of the Tsg101 UEV domain. | EMBO J | 2002 May 15 |
1 |
5 | 12802020 | TSG101 interaction with HRS mediates endosomal trafficking and receptor down-regulation. | Proc Natl Acad Sci U S A | 2003 Jun 24 |
3 |
6 | 12915533 | Tsg101 control of human immunodeficiency virus type 1 Gag trafficking and release. | J Virol | 2003 Sep |
3 |
7 | 13679614 | Association of Japanese encephalitis virus NS3 protein with microtubules and tumour susceptibility gene 101 (TSG101) protein. | J Gen Virol | 2003 Oct |
1 |
8 | 15043208 | HIV capsid assembly. | Curr HIV Res | 2003 Jan |
1 |
9 | 15044860 | Reversal of multidrug resistance of gastric cancer cells by downregulation of TSG101 with TSG101siRNA. | Cancer Biol Ther | 2004 Jun |
5 |
10 | 15053872 | Ubiquitin recognition by the human TSG101 protein. | Mol Cell | 2004 Mar 26 |
3 |
11 | 15126635 | Nedd4.1-mediated ubiquitination and subsequent recruitment of Tsg101 ensure HTLV-1 Gag trafficking towards the multivesicular body pathway prior to virus budding. | J Cell Sci | 2004 May 1 |
4 |
12 | 15163754 | Late assembly motifs of human T-cell leukemia virus type 1 and their relative roles in particle release. | J Virol | 2004 Jun |
1 |
13 | 15197357 | Pharmacogenomics on gastric cancer. | Cancer Biol Ther | 2004 Jun |
2 |
14 | 15731271 | The C-terminal half of TSG101 blocks Rous sarcoma virus budding and sequesters Gag into unique nonendosomal structures. | J Virol | 2005 Mar |
1 |
15 | 15795524 | Gag-p6 Tsg101 binding site duplications in maternal-infant HIV infection. | AIDS Res Hum Retroviruses | 2005 Mar |
1 |
16 | 16004603 | The penta-EF-hand protein ALG-2 interacts directly with the ESCRT-I component TSG101, and Ca2+-dependently co-localizes to aberrant endosomes with dominant-negative AAA ATPase SKD1/Vps4B. | Biochem J | 2005 Nov 1 |
2 |
17 | 16552148 | Structure of human TSG101 UEV domain. | Acta Crystallogr D Biol Crystallogr | 2006 Apr |
3 |
18 | 17048869 | Hydrazone- and hydrazide-containing N-substituted glycines as peptoid surrogates for expedited library synthesis: application to the preparation of Tsg101-directed HIV-1 budding antagonists. | Org Lett | 2006 Oct 26 |
3 |
19 | 17182674 | The C-terminal portion of the Hrs protein interacts with Tsg101 and interferes with human immunodeficiency virus type 1 Gag particle production. | J Virol | 2007 Mar |
3 |
20 | 17229889 | Spongiform neurodegeneration-associated E3 ligase Mahogunin ubiquitylates TSG101 and regulates endosomal trafficking. | Mol Biol Cell | 2007 Apr |
3 |
21 | 17321722 | A PKC-Sp1 signaling pathway induces early differentiation of human keratinocytes through upregulation of TSG101. | Cell Signal | 2007 Jun |
8 |
22 | 17428861 | Potent rescue of human immunodeficiency virus type 1 late domain mutants by ALIX/AIP1 depends on its CHMP4 binding site. | J Virol | 2007 Jun |
1 |
23 | 18077552 | Regulation of Tsg101 expression by the steadiness box: a role of Tsg101-associated ligase. | Mol Biol Cell | 2008 Feb |
1 |
24 | 18083557 | Protected aminooxyprolines for expedited library synthesis: application to Tsg101-directed proline-oxime containing peptides. | Bioorg Med Chem Lett | 2008 Feb 1 |
2 |
25 | 18643869 | GISP binding to TSG101 increases GABA receptor stability by down-regulating ESCRT-mediated lysosomal degradation. | J Neurochem | 2008 Oct |
1 |
26 | 18655064 | SAR by oxime-containing peptide libraries: application to Tsg101 ligand optimization. | Chembiochem | 2008 Aug 11 |
1 |
27 | 19053244 | Inhibition of HIV budding by a genetically selected cyclic peptide targeting the Gag-TSG101 interaction. | ACS Chem Biol | 2008 Dec 19 |
2 |
28 | 19210987 | The TSG101 protein binds to connexins and is involved in connexin degradation. | Exp Cell Res | 2009 Apr 1 |
1 |
29 | 19244744 | [The action of TSG101 on HIV-1 budding and related inhibitors]. | Yao Xue Xue Bao | 2008 Dec |
2 |
30 | 19542561 | Proline-rich sequence recognition: II. Proteomics analysis of Tsg101 ubiquitin-E2-like variant (UEV) interactions. | Mol Cell Proteomics | 2009 Nov |
2 |
31 | 19914066 | Application of ring-closing metathesis macrocyclization to the development of Tsg101-binding antagonists. | Bioorg Med Chem Lett | 2010 Jan 1 |
3 |
32 | 20004458 | Ubiquitination of tombusvirus p33 replication protein plays a role in virus replication and binding to the host Vps23p ESCRT protein. | Virology | 2010 Feb 20 |
2 |
33 | 20399684 | Essential role of ubiquitin and TSG101 protein in formation and function of the central supramolecular activation cluster. | Immunity | 2010 Apr 23 |
1 |
34 | 20929444 | Decoding the intrinsic mechanism that prohibits ALIX interaction with ESCRT and viral proteins. | Biochem J | 2010 Dec 15 |
4 |
35 | 21117030 | Down-regulation of TSG101 by small interfering RNA inhibits the proliferation of breast cancer cells through the MAPK/ERK signal pathway. | Histol Histopathol | 2011 Jan |
1 |
36 | 21118645 | [Expression and significance of TSG101, P21 and P300/CBP in squamous cell carcinoma and adenocarcinoma of the lung]. | Zhongguo Fei Ai Za Zhi | 2007 Jun 20 |
1 |
37 | 21643473 | Elucidation of New Binding Interactions with the Tumor Susceptibility Gene 101 (Tsg101) Protein Using Modified HIV-1 Gag-p6 Derived Peptide Ligands. | ACS Med Chem Lett | 2011 May 12 |
2 |
38 | 21875593 | ESCRT machinery potentiates HIV-1 utilization of the PI(4,5)P(2)-PLC-IP3R-Ca(2+) signaling cascade. | J Mol Biol | 2011 Oct 21 |
1 |
39 | 22102845 | Bimolecular Complementation to Visualize Filovirus VP40-Host Complexes in Live Mammalian Cells: Toward the Identification of Budding Inhibitors. | Adv Virol | 2011 Jan 1 |
1 |
40 | 22438540 | The PSAP motif within the ORF3 protein of an avian strain of the hepatitis E virus is not critical for viral infectivity in vivo but plays a role in virus release. | J Virol | 2012 May |
2 |
41 | 23104469 | Culture systems for hepatitis E virus. | J Gastroenterol | 2013 Feb |
4 |
42 | 23816704 | Identification of α-taxilin as an essential factor for the life cycle of hepatitis B virus. | J Hepatol | 2013 Nov |
1 |
43 | 24904548 | Tsg101 regulates PI(4,5)P2/Ca(2+) signaling for HIV-1 Gag assembly. | Front Microbiol | 2014 |
2 |
44 | 25682864 | Biomolecular characterization of exosomes released from cancer stem cells: Possible implications for biomarker and treatment of cancer. | Oncotarget | 2015 Feb 20 |
3 |
45 | 26608825 | TSG101, a tumor susceptibility gene, bidirectionally modulates cell invasion through regulating MMP-9 mRNA expression. | BMC Cancer | 2015 Nov 25 |
2 |
46 | 27280284 | The Race against Protease Activation Defines the Role of ESCRTs in HIV Budding. | PLoS Pathog | 2016 Jun |
1 |
47 | 27648839 | HIV-1 Vpr Abrogates the Effect of TSG101 Overexpression to Support Virus Release. | PLoS One | 2016 |
8 |
48 | 27856401 | ESCRT-I Component VPS23A Affects ABA Signaling by Recognizing ABA Receptors for Endosomal Degradation. | Mol Plant | 2016 Dec 5 |
1 |
49 | 29571744 | The NC domain of HIV-1 Gag contributes to the interaction of Gag with TSG101. | Biochim Biophys Acta Gen Subj | 2018 Jun |
7 |
50 | 29859188 | TSG101 interacts with the androgen receptor and attenuates its expression through the endosome/lysosome pathway. | Biochem Biophys Res Commun | 2018 Sep 3 |
2 |